Cusatuzumab
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML) [1].
Product Specifications
CAS Number
1864871-20-4
Product Name Alternative
ARGX-110
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/cusatuzumab.html
Purity
98.87
Solubility
H2O
Smiles
[Cusatuzumab]
Molecular Weight
(144.36 kDa)
References & Citations
[1]Riether C, et al. Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents. Nat Med. 2020; 26 (9) :1459-1467.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS656989-01 1 mg
Tissue, Total Protein, Human Adult Normal, Small intestine
Sign In for Pricing
View Details MBS656989-02 5x 1 mg
Tissue, Total Protein, Human Adult Normal, Small intestine
Sign In for Pricing
View Details 